ERN1 and prostate carcinoma: Interestingly, in humans, mutations that compromise the activity or the expression of RNase L, an IRE1-related endoribonuclease, have been implicated with increased susceptibility to prostate cancer (Carpten et al., 2002; Casey et al., 2002).